The concept of innovative drugs surged and then fell back. HOB Biotech Group dropped by more than 10%, while RemeGen, ApicHope, SHOUYAO HOLDINGS, Hotgen, and Northland all fell by more than 5%.
Biological New Drug Developer
Innovative Biopharmaceutical R&D Developer

In Vitro Diagnostic Technology and Innovative Product R&D, Manufacturer

Innovative Biopharmaceutical Manufacturer
The concept of innovative drugs surged and then fell back. HOB Biotech Group dropped by more than 10%, while RemeGen, ApicHope, SHOUYAO HOLDINGS, Hotgen, and Northland all fell by more than 5%.